Aptose Biosciences
APTO
#10443
Rank
โ‚น0.39 B
Marketcap
โ‚น154.64
Share price
0.00%
Change (1 day)
892.59%
Change (1 year)

Market capitalization of Aptose Biosciences (APTO)

Market cap: โ‚น0.39 Billion

As of February 2026 Aptose Biosciences has a market cap of โ‚น0.39 Billion. This makes Aptose Biosciences the world's 10443th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aptose Biosciences from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น0.39 B0.74%
2025โ‚น0.39 B-68.6%
2024โ‚น1.24 B-25.8%
2023โ‚น1.68 B-65.63%
2022โ‚น4.89 B-45.52%
2021โ‚น8.98 B-68.48%
2020โ‚น28.49 B-6.69%
2019โ‚น30.53 B499.53%
2018โ‚น5.09 B33.32%
2017โ‚น3.82 B211.26%
2016โ‚น1.22 B-40.9%
2015โ‚น2.07 B-52.67%
2014โ‚น4.38 B184.15%
2013โ‚น1.54 B114.23%
2012โ‚น0.72 B237.02%
2011โ‚น0.21 B-68.94%
2010โ‚น0.68 B-19.76%
2009โ‚น0.85 B129.31%
2008โ‚น0.37 B-75.34%
2007โ‚น1.51 B-25.94%
2006โ‚น2.04 B5.11%
2005โ‚น1.95 B-56.4%
2004โ‚น4.47 B-24.69%
2003โ‚น5.93 B159.86%
2002โ‚น2.28 B-58.43%
2001โ‚น5.49 B-27.29%
2000โ‚น7.56 B

End of Day market cap according to different sources

On Feb 2nd, 2026 the market cap of Aptose Biosciences was reported to be:

N/A
by Nasdaq info icon info icon
โ‚น0.39 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ImmunoGen
IMGN
โ‚น788.96 B 199,783.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
โ‚น12.84 B 3,153.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
โ‚น0.11 B-70.72%๐Ÿ‡บ๐Ÿ‡ธ USA